Carter's (NYSE: CRI) Posts 8.1% Revenue Growth in Q1 2026 as Comparable Sales Climb

Carter's, Inc. (NYSE: CRI) reported first-quarter fiscal 2026 net sales of $681 million, up 8.1% from $630 million in the same period a year ago, as U.S. Retail comparable sales posted a fourth consecutive quarter of growth. Shares added $0.17, or 0.51%, to close at $33.34, with the stock continuing to recover from its 52-week low of $23.38.

Q1 2026 At a Glance

• Net sales: $681.11 million vs. $629.83 million in Q1 2025 — growth of 8.1%
• U.S. Retail comparable sales: increased 10.5% year-over-year
• Net income: $14.3 million, or $0.39 per share
• Operating margin: 4.2% vs. 4.1% in Q1 2025
• Gross margin (trailing): 45.4%
• Trailing P/E: 13.2x | Forward P/E: 9.3x
• Market cap: $1.2 billion

What Drove the Results

The sequential improvement in U.S. Retail comparable sales — now positive for four straight quarters — points to steady demand recovery in the children's apparel segment, where Carter's holds leading brand recognition. Operating margin expanded modestly to 4.2%, reflecting disciplined cost management against a backdrop of 45.4% gross margin, while the overall operating margin on a trailing basis stands at 8.6%, suggesting the quarter's result came in below the company's full-year run rate.

Revenue growth of 7.6% on a trailing year-over-year basis aligns closely with the Q1 print, indicating the business has maintained consistent momentum. Net income growth of 4.0% on a trailing basis, however, lags the top-line pace — a reflection of the 3.2% net margin, which leaves limited room for earnings leverage even as sales recover. The results were confirmed via an 8-K filed with the SEC on May 6, 2026 under Results of Operations.

Wall Street View

Analyst sentiment on (NYSE: CRI) remains notably divided. As of the May 1, 2026 consensus, the ratings stand at 2 Strong Buy, 5 Hold, 6 Sell, and 1 Strong Sell — a meaningful skew toward caution. Compared to the April 1, 2026 prior period, the Hold count increased from 4 to 5, suggesting some analysts moved from neutral to a more cautious stance even as the revenue recovery continued. No price target data is available to benchmark the current $33.34 share price.

Investor Takeaway

The Q1 2026 results demonstrate that Carter's (NYSE: CRI) is executing on its retail recovery, with four consecutive quarters of U.S. comparable sales growth and top-line expansion of 8.1% providing tangible evidence of improving consumer demand. However, the compressed net margin of 3.2% and a predominantly cautious analyst consensus — with 7 Sell or Strong Sell ratings out of 14 — suggest the market is waiting for more durable profitability improvement before reassigning a materially higher valuation. The forward P/E of 9.3x reflects that expectation gap between revenue momentum and bottom-line conviction.